(Q51121767)

30 March 2018

title

Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats. (English)

1 reference

30 March 2018

author name string

D Charrier

1

1 reference

30 March 2018

L Dangoumau

2

1 reference

30 March 2018

A J Puech

3

1 reference

30 March 2018

M Hamon

4

1 reference

30 March 2018

M H Thiébot

5

1 reference

30 March 2018

publication date

1 September 1995

1 reference

30 March 2018

number of pages

8

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

30 March 2018

volume

121

1 reference

30 March 2018

issue

1

1 reference

30 March 2018

page(s)

127-134

1 reference

30 March 2018

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02245599

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245599

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245599

Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245599

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245599

Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.

21 January 2018

1 reference

12 December 2020

Anxiolytic effects of CCK-B antagonists

1 reference

12 December 2020

Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test

1 reference

12 December 2020

Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients

1 reference

12 December 2020

CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens.

1 reference

12 December 2020

Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.

1 reference

12 December 2020

CCK in animal and human research on anxiety

1 reference

12 December 2020

Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.

1 reference

12 December 2020

The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.

1 reference

12 December 2020

A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder

1 reference

12 December 2020

Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behaviour?

1 reference

12 December 2020

Effects of 5-HT1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat.

1 reference

12 December 2020

Heterogeneity of CCK-B receptors involved in animal models of anxiety

1 reference

12 December 2020

The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze

1 reference

12 December 2020

Safety signal withdrawal: a behavioural paradigm sensitive to both "anxiolytic" and "anxiogenic" drugs under identical experimental conditions.

1 reference

12 December 2020

Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys

1 reference

12 December 2020

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

1 reference

12 December 2020

Attenuation of induced-anxiety in rats by chlordiazepoxide: role of raphe dorsalis benzodiazepine binding sites and serotoninergic neurons.

1 reference

12 December 2020

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

12 December 2020

Enzyme-resistant CCK analogs with high affinities for central receptors.

1 reference

12 December 2020

Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents

1 reference

12 December 2020

The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice.

1 reference

12 December 2020

Biological actions of cholecystokinin

1 reference

12 December 2020

'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice

1 reference

12 December 2020

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245599

1 reference

30 March 2018

1 reference

30 March 2018